Target intelligence / Profile preview

Ribonuclease H2 subunit B (RNASEH2B)

Target
RNASEH2B
Molecular classification
Enzyme auxiliary subunit, DNA repair protein, RNA-binding protein, Part of ribonuclease H2 complex
01

Overview

Ribonuclease H2 subunit B is an essential non-catalytic subunit of the RNase H2 enzyme complex, which, together with subunits A and C, is responsible for removing misincorporated ribonucleotides from DNA and degrading RNA/DNA hybrids formed during replication and transcription. Its key structural feature is a C-terminal PIP box motif, allowing interaction with proliferating cell nuclear antigen (PCNA) and localization to DNA replication foci, thus facilitating genome surveillance and repair. Mutations in RNASEH2B disrupt ribonucleotide excision repair and cause Aicardi-Goutières syndrome, a severe neuroinflammatory and autoimmune disease characterized by immune system activation due to accumulated DNA damage and faulty nucleic acid metabolism. This subunit does not possess enzymatic activity by itself but is critical for the function and stability of the RNase H2 complex.

Other names
Ribonuclease H2, subunit BRNase H2 subunit BRibonuclease HI subunit BDLEU8AGS2FLJ11712Deleted in lymphocytic leukemia 8Aicardi-Goutières syndrome 2 proteinRNH2B_HUMAN
02

Mechanism of action

For a hypothetical inhibitor: prevention of ribonucleotide excision repair, increased genome instability, or modulation of immune response For genetic rescue/modification: restoration of ribonucleotide excision function, reduction of R-loop accumulation

03

Biological functions

Genomic surveillanceDNA replicationDNA repairRibonucleotide excision repairDegradation of RNA/DNA hybridsInteraction with PCNA during DNA synthesisMaintenance of R-loop homeostasis
04

Disease associations

Neurodegenerative disease (Aicardi-Goutières syndrome)Autoimmune disorderInflammatory disease
05

Safety considerations

Disruption of RNASEH2B function leads to genome instability, autoinflammation, and neurotoxicityPotential for DNA damage, triggering a p53-dependent DNA damage response and immune activation
06

Biomarkers

Mutations in RNASEH2B gene for diagnosis of Aicardi-Goutières syndrome (especially for genetic testing)Increased interferon-alpha activity as a functional biomarker for AGS

Beyond the preview

Go deeper on Ribonuclease H2 subunit B (RNASEH2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribonuclease H2 subunit B (RNASEH2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call